@article{HBSN20900,
author = {Susana Roselló and Ricard Borrás and Andrés Cervantes},
title = {Maintenance with single agent bevacizumab fails to improve disease-control in metastatic colorectal cancer},
journal = {Hepatobiliary Surgery and Nutrition},
volume = {7},
number = {5},
year = {2018},
keywords = {},
abstract = {The availability of biologicals, such as anti-EFGR and anti-VEGF antibodies in combination with chemotherapy (ChT), has improved prognosis of metastatic colorectal cancer (mCRC). However, the administration of drug combinations for a prolonged time implies an increased rate of toxicities, which is why some strategies to de-escalate treatment intensity have been studied.},
issn = {2304-389X}, url = {https://hbsn.amegroups.org/article/view/20900}
}